Publications by authors named "Andreas Kapatais"

One of the World Health Organization's targets for the 2030 viral hepatitis elimination strategy is to reduce new hepatitis C (HCV) infections. In Athens, Greece, people who inject drugs (PWID) have a high HCV prevalence, with increasing trends since the 2000s. This analysis aims to assess primary HCV incidence among PWID during 2012-2020.

View Article and Find Full Text PDF
Article Synopsis
  • High mortality rates among people who inject drugs (PWID) in Greece, primarily due to overdose and HIV, have been documented in a study covering 2018-2022.
  • The study found a crude mortality rate of 3.52 deaths per 100 person-years, with notable increases in Athens, and highlighted that younger, daily injectors not in treatment had higher risks of death.
  • Results indicate an urgent need for preventive measures, especially in Thessaloniki, and suggest that the COVID-19 pandemic may have exacerbated these trends in Athens.
View Article and Find Full Text PDF

Background And Aims: Hepatitis D virus (HDV) underdiagnosis remains common. We assessed the HDV screening and prevalence rates in HBsAg-positive patients seen at tertiary liver centres throughout Greece as well as factors affecting HDV diagnosis.

Methods: All adult HBsAg-positive patients seen within the last 5 years were included.

View Article and Find Full Text PDF

Background: Tenofovir alafenamide (TAF) has exhibited a favourable safety profile on estimated glomerular filtration (eGFR) and bone mineral density (BMD), but has not been extensively studied in patients with renal impairment and/or BMD disorders.

Aims: To assess predictors of eGFR changes and other safety and efficacy outcomes during 24-month TAF therapy in patients with chronic hepatitis B with renal and/or BMD disorders/risks.

Methods: Adult patients who started TAF at 13 clinics throughout Greece were prospectively included.

View Article and Find Full Text PDF